Correlation Between Solidion Technology and Santen Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Solidion Technology and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Solidion Technology and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Solidion Technology and Santen Pharmaceutical Co, you can compare the effects of market volatilities on Solidion Technology and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Solidion Technology with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Solidion Technology and Santen Pharmaceutical.
Diversification Opportunities for Solidion Technology and Santen Pharmaceutical
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Solidion and Santen is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Solidion Technology and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and Solidion Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Solidion Technology are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of Solidion Technology i.e., Solidion Technology and Santen Pharmaceutical go up and down completely randomly.
Pair Corralation between Solidion Technology and Santen Pharmaceutical
Considering the 90-day investment horizon Solidion Technology is expected to generate 5.82 times more return on investment than Santen Pharmaceutical. However, Solidion Technology is 5.82 times more volatile than Santen Pharmaceutical Co. It trades about 0.11 of its potential returns per unit of risk. Santen Pharmaceutical Co is currently generating about -0.31 per unit of risk. If you would invest 38.00 in Solidion Technology on August 27, 2024 and sell it today you would earn a total of 6.00 from holding Solidion Technology or generate 15.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Solidion Technology vs. Santen Pharmaceutical Co
Performance |
| Timeline |
| Solidion Technology |
| Santen Pharmaceutical |
Solidion Technology and Santen Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Solidion Technology and Santen Pharmaceutical
The main advantage of trading using opposite Solidion Technology and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Solidion Technology position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.| Solidion Technology vs. Procter Gamble | Solidion Technology vs. Lincoln Electric Holdings | Solidion Technology vs. Uber Technologies | Solidion Technology vs. Nextplat Corp |
| Santen Pharmaceutical vs. Ono Pharmaceutical Co | Santen Pharmaceutical vs. GSK plc | Santen Pharmaceutical vs. Grifols SA ADR | Santen Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |